Skip to content

Drug interactions

Glecaprevir / pibrentasvir + Olmesartan

Severity: Moderate

Glecaprevir / pibrentasvir and Olmesartan: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Glecaprevir and pibrentasvir inhibit hepatic uptake transporters, which may raise olmesartan plasma concentrations. Higher exposure could increase the risk of hypotension, hyperkalemia and renal effects.

What this interaction means in plain words

Glecaprevir / pibrentasvir and Olmesartan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Moderate

Why it happens

Inhibition of OATP1B1/1B3 hepatic uptake transport reduces olmesartan clearance.

What to do

Monitor blood pressure, potassium and renal function during the hepatitis C treatment course. Reduce the olmesartan dose if hypotension occurs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Glecaprevir / pibrentasvir and Olmesartan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Glecaprevir / pibrentasvir with Olmesartan?

MediHelp rates the interaction as moderate. Glecaprevir / pibrentasvir and Olmesartan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Glecaprevir and pibrentasvir inhibit hepatic uptake transporters, which may raise olmesartan plasma concentrations. Higher exposure could increase the risk of hypotension, hyperkalemia and renal effects.

How serious is the interaction between Glecaprevir / pibrentasvir and Olmesartan?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood pressure, potassium and renal function during the hepatitis C treatment course. Reduce the olmesartan dose if hypotension occurs.

What other medicines interact with Olmesartan?

MediHelp also lists interactions of Olmesartan with, for example, Aliskiren, Sparsentan, Aldesleukin. The full list is on the Olmesartan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in